Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic
Semaglutide mimics GLP-1 activity
This option targets hair loss directly while reducing the risk of systemic side effects
The semaglutide with B12 combination has become standard in many protocols for this reason
Here is what different types of healthcare professionals advise
Possible side effects of this medication include gastrointestinal symptoms, nausea, vomiting, loss of appetite, abdominal pain, and headache